US Stock MarketDetailed Quotes

ROIV Roivant Sciences

Watchlist
  • 12.040
  • -0.070-0.58%
Trading Dec 12 12:05 ET
8.76BMarket Cap2.07P/E (TTM)

Roivant Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Roivant Sciences Q2 2025 Earnings Date

Currency：USDNov 12, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
51.47M
4.47M
-46.99M
Miss Est.
+38.72%
+22.67%
-91.31%
EPS
-0.25
-0.31
-0.06
Miss Est.
+38.13%
+22.50%
-25.30%
Analyst Rating
Strong Buy

Dec 11, 2024

Roivant Sciences Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 27.101M--
--2025/Q3-- / 5.001M--
Nov 12, 20242025/Q229.262M / 51.467M--
Aug 8, 20242025/Q155.132M / 29.589M--
May 30, 20242024/Q428.930M / 30.944M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 27.101M--
--2025/Q3-- / 5.001M--
Nov 12, 20242025/Q229.262M / 51.467M--
Aug 8, 20242025/Q155.132M / 29.589M--
May 30, 20242024/Q428.930M / 30.944M--

Unlock Free Earnings Estimates

Roivant Sciences Earnings Reports

  • 10-Q: Q2 2025 Earnings Report

    Nov 12 13:24 ET

  • 8-K: Roivant Reports Financial Results for the Second Quarter Ended September 30, 2024, and Provides Business Update

    Nov 12 09:31 ET

  • 10-Q: Q1 2025 Earnings Report

    Aug 9 16:37 ET

  • 8-K: Roivant Reports Financial Results for the First Quarter Ended June 30, 2024, and Provides Business Update

    Aug 8 07:19 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 11, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data